HIV :: World Bank to lend 250 million dollars for National AIDS Program, India
The World Bank today said it will lend 250 million dollars to India for supporting the National AIDS Control Programme over the next five years.
The World Bank today said it will lend 250 million dollars to India for supporting the National AIDS Control Programme over the next five years.
Kaposi sarcoma is unique among cancers because most tumors grow from a small number of different cells, whereas nearly all other cancers arise from a single cell, according to a study published online July 10 in the Journal of the National Cancer Institute.
A Penn State researcher argues that ambiguous international rules outlining when and how governments may “break” pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.
Researchers from the University of Granada and Hospital Carlos III in Madrid, verified that maslinic acid — found in wax from olive skin — inhibits serin-protease, the enzyme used by HIV to release itself from the infected cell into the extracellular environment.
Nearly half of all people infected with HIV/AIDS are now women, the majority of whom contracted the disease through sexual intercourse with male partners.
After leveling off for more than two years, and declining in 2006, new syphilis cases spiked in New York City during the first three months of 2007. The Health Department announced today that doctors reported 260 cases of primary and secondary syphilis during January, February and March, compared with 128 cases during the same period last year.
Indian cinemagoers will soon see short films by India’s top directors about the impact of HIV/AIDS, which will be screened ahead of Bollywood movie blockbusters, reported by PTI.
Indian government put the figure of people suffering from HIV/AIDS in the country at 2.5 million, a drastic reduction of around 50 per cent from last year.
United Nations Deputy Secretary-General Asha-Rose Migiro today called for a more broad-based effort to tackle the impact of HIV/AIDS on women and girls.
TMC125 (etravirine, ETR), Tibotec’s investigational next-generation non-nucleoside reverse transcriptase inhibitor (NNRTI), demonstrated significant efficacy in patients with NNRTI resistance, according to the 24-week primary endpoint analysis from two ongoing, phase III studies published in the 7 July, 2007, issue of The Lancet.